ACTIVE IMMUNOTHERAPY TRIALS ON ACUTE LYMPHOID LEUKEMIA LYMPHOSARCOMA AND ACUTE MYELOID LEUKEMIA.MATHE G; SCHWARZENBERG L; DELGADO M et al.1977; EUROP. J. CANCER; G.B.; DA. 1977; VOL. 13; NO 4-5; PP. 445-455; BIBL. 2 P. 1/2Article

ETUDE PHASE II DES TROIS NOUVELLES NITROSOUREES, UNE AMERICAINE: LA CHLOROZOTOCINE ET DEUX FRANCAISES: LE RFCNU ET LE RPCNUMATHE G; SCHEIN PS; DE VASSAL F et al.1982; SEM. HOP.; ISSN 0037-1777; FRA; DA. 1982; VOL. 58; NO 33; PP. 1867-1871; ABS. ENG; BIBL. 20 REF.Article

COMPARISON OF THE RESTORATION EFFECT OF PSEUDOMONAS AERUGINOSA, BCG AND POLY I: POLY C ON CANCER PATIENTS NON RESPONSIVE TO RECALL ANTIGEN DELAYED HYPERSENSITIVITY.MATHE G; DE VASSAL F; GOUVEIA J et al.1977; BIOMEDICINE; FR.; DA. 1977; VOL. 27; NO 9-10; PP. 328-330; ABS. FR.; BIBL. 11 REF.Article

LA LEUCEMIE AIGUE MONOCYTOIDE ET LA LEUCEMIE AIGUE MYELOMONOCYTOIDE: LE TRAITEMENT PAR LE VP16213AMIEL JL; SCHWARZENBERG L; MUSSET M et al.1974; BULL. CANCER; FR.; DA. 1974; VOL. 61; NO 3; PP. 419-426; ABS. ANGL.; BIBL. 12REF.Article

LA PREVENTION DES MENINGITES LEUCEMIQUESPOUILLART P; SCHWARZENBERG L; BELPOMME D et al.1974; BULL. CANCER; FR.; DA. 1974; VOL. 61; NO 3; PP. 403-410; ABS. ANGL.; BIBL. 11REF.Article

TRANSFORMATION LEUCEMIQUE DES HEMATOSARCOMES LYMPHOMES NON-HODGKINIENS. EFFICACITE DE L'IMMUNOTHERAPIEMATHE G; POUILLART P; SCHWARZENBERG L et al.1974; BULL. CANCER; FR.; DA. 1974; VOL. 61; NO 1; PP. 69-78; ABS. ANGL.; BIBL. 4REF.; (LYMPHORETICULOSARCOMES. COMMUN. ASSOC. FR. ETUD. CANCER REUN. CANCEROL. FED. NATL. CENT. LUTTE CONTRE CANCER; PARIS; 1973)Conference Paper

THE COMMON ACUTE LYMPHOID LEUKEMIA ANTIGEN ON B CELLS OF CHRONIC LYMPHOID LEUKEMIA AND NON-HODGKIN'S LYMPHOMACANON C; AUGIER C; REIZENSTEIN P et al.1983; BIOMEDICINE AND PHARMACOTHERAPY; ISSN 0753-3322; FRA; DA. 1983; VOL. 37; NO 2; PP. 90-92; ABS. FRE; BIBL. 11 REF.Article

PHASE II TRIAL OF ACTIVE IMMUNOTHERAPY OF ACUTE MYELOID LEUKEMIAMATHE G; MUSSET M; SCHWARZENBERG L et al.1975; BIOMEDECINE; FR.; DA. 1975; VOL. 23; NO 7; PP. 291-293; ABS. FR.; BIBL. 18 REF.Article

FOLLOW- UP OF THE FIRST (1962) PILOT STUDY ON ACTIVE IMMUNOTHERAPY OF ACUTE LYMPHOID LEUKAEMIA: A CRITICAL DISCUSSION.MATHE G; AMIEL JL; SCHWARZENBERG L et al.1977; BIOMEDICINE; FR.; DA. 1977; VOL. 26; NO 1; PP. 29-35; ABS. FR.; BIBL. 2 P. 1/2Article

UNE CLASSIFICATION DES LEUCEMIES AIGUES. INTERET THERAPEUTIQUE ET PRONOSTIQUE POUR LES LEUCEMIES AIGUES LYMPHOIDESMATHE G; POUILLART P; STERESCU M et al.1972; ANN. MED. INTERNE; FR.; DA. 1972; VOL. 123; NO 5; PP. 487-489; BIBL. 3 REF.Serial Issue

NEOANTIGENES DES CELLULES LEUCEMIQUES HUMAINES ET ANTICORPS DANS LE SERUM DES LEUCEMIQUESDORE JF; MOTTA R; MARKHOLEV L et al.1971; IN: YUBILEINA SEDMISTA V CHEST 25-TA GODISHINA NA SETSIALISTCHESKATA REVOLINTSIYA V BULGARIYA. SOFIA, 1969. NAUCHNI TRUDOVE; SOFIA; MED. I FIZKULT; DA. 1971; PP. 341-343; ABS. RUSSE ANGL.; BIBL. 8REF.Conference Proceedings

STUDY OF NITROSOUREA GLYCOSYL ANALOGS-V. AN ORIENTED PHASE II TRIAL OF RFCNUMATHE G; SCHEIN P; MACDONALD JS et al.1982; EUR. J. CANCER CLIN. ONCOL.; ISSN 0277-5379; GBR; DA. 1982; VOL. 18; NO 8; PP. 727-732; BIBL. 23 REF.Article

TRAITEMENT DES LEUCEMIES ET DES LYMPHOMES PAR LES INTERFERONSMISSET JL; MATHE G; GASTIABURU J et al.1982; BIOMEDICINE; ISSN 0300-0893; FRA; DA. 1982; VOL. 36; NO 3; PP. 167-170; ABS. ENG; BIBL. 14 REF.Article

ESSAIS D'IMMUNOTHERAPIE ACTIVE DANS LA LEUCEMIE AIGUE LYMPHOIDE. INFLUENCE DE DIVERS FACTEURS SUR LES RESULTATS. ETUDE DE 100 MALADESMATHE G; POUILLART P; SCHWARZENBERG L et al.1973; NOUV. PRESSE MED.; FR.; DA. 1973; VOL. 2; NO 9; PP. 557-562; BIBL. 20REF.Serial Issue

PHASE II TRIAL OF ACLACINOMYCIN IN ACUTE LEUKEMIA AND LYMPHOSARCOMAMATHE G; GIL MA; DELGADO M et al.1980; RECENT RESULTS CANCER RES.; ISSN 0080-0015; USA; DA. 1980; NO 74; PP. 217-222; BIBL. 18 REF.Article

PRELIMINARY RESULTS OF PHASE I AND II CLINICAL TRIALS OF RFCNU, A NEW NITROSOUREA SUGAR DERIVATIVE INDIGESTIVE TRACT TUMOURS.MATHE G; SERROU B; HAYAT M et al.1977; BIOMEDICINE; FR.; DA. 1977; VOL. 27; NO 8; PP. 294-297; ABS. FR.; BIBL. 4 REF.Article

RESULTS IN CHILDREN OF ACUTE LYMPHOID LEUKEMIA PROTOCOL ICIG-ALL 9 CONSISTING OF CHEMOTHERAPY FOR ONLY NINE MONTHS FOLLOWED BY ACTIVE IMMUNOTHERAPY. COMPARISON WITH THE RESULTS OF MORE PROLONGED CHEMOTHERAPY PROTOCOLS. RECOGNITION OF TWO GROUPS OF ACUTE LYMPHOID LEUKAEMIAS FROM PROGNOSTIC PARAMETERS.MATHE G; DE VASSAL F; SCHWARZENBERG L et al.1977; CANCER IMMUNOL. IMMUNOTHERAPY; GERM.; DA. 1977; VOL. 2; NO 4; PP. 225-232; BIBL. 1 P. 1/2Article

LEUCEMIE AIGUE LYMPHOIDE DE L'ENFANT: RESULTATS DES PROTOCOLES ICIG-LAL 9 ET 10, COMPORTANT RESPECTIVEMENT UNE COURTE ET UNE LONGUE CHIMIOTHERAPIE PRE-IMMUNOTHERAPIQUE. RECONNAISSANCE DE DEUX GROUPES DE PATIENTS SELON LE PRONOSTIC.MATHE G; DE VASSAL F; SCHWARZENBERG L et al.1977; NOUV. PRESSE MED.; FR.; DA. 1977; VOL. 6; NO 27; PP. 2401-2407; ABS. ANGL.; BIBL. 36 REF.Article

HAUTE FREQUENCE DE REMISSIONS DANS LA LEUCEMIE AIGUE MYELOIDE (LAM), PAR LA COMBINAISON D'ADRIAMYCINE, DE VINCRISTINE ET DE CYTOSINE ARABINOSIDE. IMPORTANCE DES SOINS HEMATOLOGIQUES INTENSIFS.MATHE G; POUILLART P; DE VASSAL F et al.1976; NOUV. PRESSE MED.; FR.; DA. 1976; VOL. 5; NO 28; PP. 1758-1759; BIBL. 9 REF.Article

PHASE II CLINICAL TRIAL WITH VINDESINE FOR REMISSION INDUCTION IN ACUTE LEUKEMIA, BLASTIC CRISIS OF CHRONIC MYELOID LEUKEMIA, LYMPHOSARCOMA, AND HODGKIN'S DISEASE: ABSENCE OF CROSS-RESISTANCE WITH VINCRISTINE.MATHE G; MISSET JL; DE VASSAL F et al.1978; CANCER TREATM. REP.; USA; DA. 1978; VOL. 62; NO 5; PP. 805-809; BIBL. 21 REF.Article

LEUCEMIE AIGUE LYMPHOIDE: INDUCTION CONSTANTE DE REMISSION PAR LA COMBINAISON DE PREDSINONE, VINCRISTINE ET L-ASPARAGINASE (20 CAS)MATHE G; POUILLART P; DE VASSAL F et al.1976; NOUV. PRESSE MED.; FR.; DA. 1976; VOL. 5; NO 23; PP. 1491; BIBL. 8 REF.Article

IMMUNOBLASTIC ACUTE LYMPHOID LEUKAEMIAMATHE G; BELPOMME D; DANTCHEV D et al.1974; BIOMEDICINE; FR.; DA. 1974; VOL. 20; NO 5; PP. 333-340; H.T. 1; ABS. FR.; BIBL. 19REF.Article

TRAITEMENT DES LEUCEMIES ET DES LYMPHOMES PAR LES INTERFERONS. II: ESSAI PHASE II DE TRAITEMENT DE LA LEUCEMIE LYMPHOIDE CHRONIQUE PAR L'INTERFERON ALPHA HUMAIN +MISSET JL; MATHE G; GASTIABURU J et al.1982; BIOMEDICINE; ISSN 0300-0893; FRA; DA. 1982; VOL. 36; NO 2; PP. 112-116; ABS. ENG; BIBL. 9 REF.Article

AN INTENSIVE CHEMO- OR CHEMOIMMUNOTHERAPY REGIMEN FOR PATIENTS WITH INTERMEDIATE AND POOR-PROGNOSIS ACUTE LYMPHATIC LEUKEMIA AND LEUKEMIC LYMPHOBLASTIC LYMPHOSARCOMA: PRELIMINARY RESULTS WITH 14-MONTH MEDIAN FOLLOW-UPMISSET JL; DE VASSAL F; DELGADO M et al.1982; RECENT RESULTS CANCER RES.; ISSN 0080-0015; USA; DA. 1982; NO 80; PP. 29-35; BIBL. 13 REF.Article

IMMUNOBLASTIC LYMPHOSARCOMA, A CYTOLOGICAL AND CLINICAL ENTITY.MATHE G; BELPOMME D; DANTCHEV D et al.1975; BIOMEDICINE; FR.; DA. 1975; VOL. 22; NO 6; PP. 473-488; H.T. 2; ABS. FR.; BIBL. 52 REF.Article